These observations indicate that the growth-suppressive effects of PDE10A inhibition in colorectal cancer cells are critically dependent on PKG-mediated downregulation of β-catenin signaling, a mechanism not effectively reproduced by PKA activation. The gene discussed is PDE10A; the disease is colorectal cancer.